FDA okays second omicron booster for people at high risk from covid

United States News News

FDA okays second omicron booster for people at high risk from covid
United States Latest News,United States Headlines
  • 📰 washingtonpost
  • ⏱ Reading Time:
  • 62 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 28%
  • Publisher: 72%

Breaking news: FDA clears a second omicron-targeting booster shot for people who are at high risk from the coronavirus

The action appears likely to provide a measure of reassurance to people whose age or medical issues put them at risk of serious illness if they are infected by the coronavirus. Some got updated boosters last fall, soon after the omicron-targeting shots werethe mRNA vaccines have a history of waning protection within months of administration.

Even as some people have been clamoring for a second booster, others appear unconcerned. Only about 42 percent of people 65 and older have received the first bivalent booster,Experts have expressed differing views on the necessity of a second bivalent dose. While some say little data exists to justify it, others believe the extra shot is a good option for high-risk individuals. The United Kingdom and Canada already are offering spring booster shots for vulnerable individuals.

“Bivalent mRNA booster vaccination in adults aged 65 years or older is an effective and essential tool to reduce their risk of hospitalisation and death due to covid-19,” wrote study co-author Ronen Arbel of Clalit Health Services, a health-care organization in Israel.

The FDA still plans to move to a once-a-year coronavirus vaccine shot for most Americans — a timetablein January that is intended to coincide with annual flu inoculations in the fall. The FDA and its advisers hope the simplified schedule will encourage more people to get coronavirus vaccine doses. Officials will select a reformulated dose in coming months based on which coronavirus strain scientists think is most likely to be circulating in fall and winter.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

washingtonpost /  🏆 95. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Supreme Court to Decide Future of Abortion Pill MifepristoneSupreme Court to Decide Future of Abortion Pill MifepristoneWATCH: The FDA approved mifepristone initially some 20 years ago, but now the question is whether the FDA did it the right way, says legal analyst Dan Eaton.
Read more »

Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.Single Dose of Omicron-Targeting Vaccines to Become Main Covid-19 Shot in U.S.Americans seeking messenger RNA vaccines for Covid-19 for the first time will get one shot targeting both the Omicron variant and the original strain of the virus
Read more »

Concerns that Texas abortion ruling will upend FDA authority are ‘totally alarmist’: Sen. CassidyConcerns that Texas abortion ruling will upend FDA authority are ‘totally alarmist’: Sen. CassidyThe Louisiana Republican said the Supreme Court ruling last year that overturned Roe v. Wade 'was the correct decision' in an exclusive interview on NBC News' 'Meet the Press.'
Read more »

Sen. Cassidy dismisses Democrats’ concerns over FDA authority after abortion pill rulingSen. Cassidy dismisses Democrats’ concerns over FDA authority after abortion pill rulingSen. Bill Cassidy on Sunday described fears by Democrats that a court ruling against the abortion pill mifepristone could uproot the Food and Drug Administration’s approval of other drugs as vastly exaggerated.
Read more »

Adderall shortage continues, FDA says ‘supply is increasing’Adderall shortage continues, FDA says ‘supply is increasing’For months now, some people who need ADHD medication are struggling to find Adderall. MORE ⬇️
Read more »



Render Time: 2025-02-24 03:59:09